Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsJanuary 4, 2021
A new class of opioid withdrawal treatment emerges in The Sparrow Therapy System — the first clinically proven, drug-free, needle-free, wearable neurostimulation solution for opioid withdrawal relief
Read MoreRead More Nine of the Foremost Pain Management Physicians Join the Spark Biomedical, Inc. Medical Advisory BoardAugust 28, 2020
Spark Biomedical, developer of the Sparrow ™ Therapy System — a discrete, wearable, over-the-ear, medical device designed for opioid withdrawal relief — announces the official formation of the company’s Medical Advisory Board on Pain Management.
Read MoreRead More Spark Biomedical Receives $217K NIH Grant to Help Opioid-Addicted NewbornsOctober 18, 2019
FUNDS TO VALIDATE TRANSCUTANEOUS AURICULAR NEUROSTIMULATION FOR RELIEVING WITHDRAWAL SYMPTOMS IN INFANTS BORN WITH NEONATAL ABSTINENCE SYNDROME (NAS) Dallas, TX, October 18, 2019 — Spark Biomedical, Inc., a neurostimulation device company developing solutions for opioid withdrawal, received a $217,690 SBIR grant from the National Institutes of Health HEAL initiative. The grant (1R43DA050360-01) will be used to validate the use of neurostimulation to relieve withdrawal symptoms in infants born with neonatal abstinence syndrome (NAS).
Read MoreRead More Texas A&M alumnus’ biomedical company wins 2019 Texas A&M New Ventures CompetitionMay 20, 2019
A Texas A&M University former student’s startup, Spark Biomedical, was awarded $50,000 as the winner of the 2019 Texas A&M New Ventures Competition (TNVC) hosted by the Texas A&M Engineering Experiment Station (TEES). Daniel Powell is CEO of the medical device company, which is developing noninvasive neurostimulation solutions for opioid withdrawal and addiction.
Read MoreRead More Houston Based Galen Data and Spark Biomedical Reach AgreementMay 6, 2019
Partnership between Galen Data and Spark Biomedical strengthens their combined capability in support of connected medical devices and the ability to treat opioid withdrawal.
Read MoreRead More